LV12634A - Watersoluble azole antifungals - Google Patents

Watersoluble azole antifungals

Info

Publication number
LV12634A
LV12634A LV000153A LV000153A LV12634A LV 12634 A LV12634 A LV 12634A LV 000153 A LV000153 A LV 000153A LV 000153 A LV000153 A LV 000153A LV 12634 A LV12634 A LV 12634A
Authority
LV
Latvia
Prior art keywords
compounds
watersoluble
well
azole antifungals
stereometric
Prior art date
Application number
LV000153A
Other languages
English (en)
Other versions
LV12634B (lv
Inventor
Jan Heeres
Leo Jacobus Jozef Backx
Van Der Luc Alfons Leo Eycken
Frank Christopher Odds
Jean Louis Mesens
Original Assignee
Janssen Pharmaceutica Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Janssen Pharmaceutica Nv filed Critical Janssen Pharmaceutica Nv
Publication of LV12634A publication Critical patent/LV12634A/lv
Publication of LV12634B publication Critical patent/LV12634B/lv

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D249/00Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
    • C07D249/02Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D249/081,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10Antimycotics
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D231/00Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/12Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D233/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/56Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02Phosphorus compounds
    • C07F9/547Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/6558Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing at least two different or differently substituted hetero rings neither condensed among themselves nor condensed with a common carbocyclic ring or ring system
    • C07F9/65586Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing at least two different or differently substituted hetero rings neither condensed among themselves nor condensed with a common carbocyclic ring or ring system at least one of the hetero rings does not contain nitrogen as ring hetero atom

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Oncology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Communicable Diseases (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Biochemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Separation Of Suspended Particles By Flocculating Agents (AREA)
  • External Artificial Organs (AREA)
  • Detergent Compositions (AREA)
  • Footwear And Its Accessory, Manufacturing Method And Apparatuses (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
LVP-00-153A 1994-01-24 2000-11-09 Ūdenī šķīstoši azola antimikotiskie līdzekļi LV12634B (lv)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US18535294A 1994-01-24 1994-01-24

Publications (2)

Publication Number Publication Date
LV12634A true LV12634A (lv) 2001-03-20
LV12634B LV12634B (lv) 2001-07-20

Family

ID=22680644

Family Applications (1)

Application Number Title Priority Date Filing Date
LVP-00-153A LV12634B (lv) 1994-01-24 2000-11-09 Ūdenī šķīstoši azola antimikotiskie līdzekļi

Country Status (31)

Country Link
US (1) US5707977A (lv)
EP (1) EP0741737B1 (lv)
JP (1) JP3764750B2 (lv)
KR (1) KR100352147B1 (lv)
CN (1) CN1078210C (lv)
AT (1) ATE186540T1 (lv)
AU (1) AU688455B2 (lv)
CA (1) CA2179640C (lv)
CY (1) CY2176B1 (lv)
CZ (1) CZ288544B6 (lv)
DE (1) DE69513279T2 (lv)
DK (1) DK0741737T3 (lv)
ES (1) ES2141329T3 (lv)
FI (1) FI116057B (lv)
GR (1) GR3032550T3 (lv)
HU (1) HU227281B1 (lv)
IL (1) IL112413A (lv)
LV (1) LV12634B (lv)
MY (1) MY111814A (lv)
NO (1) NO308412B1 (lv)
NZ (1) NZ278882A (lv)
PH (1) PH31664A (lv)
PL (1) PL181947B1 (lv)
PT (1) PT741737E (lv)
RU (1) RU2156764C2 (lv)
SG (1) SG48386A1 (lv)
SI (1) SI0741737T1 (lv)
SK (1) SK282059B6 (lv)
TW (1) TW376385B (lv)
WO (1) WO1995019983A1 (lv)
ZA (1) ZA95521B (lv)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW457240B (en) * 1995-04-20 2001-10-01 Janssen Pharmaceutica Nv Novel triazolones as apolipoprotein-B synthesis inhibitors
SK27097A3 (en) * 1995-06-02 1997-09-10 Schering Corp Tetrahydrofuran antifungals
US5698557A (en) * 1995-06-19 1997-12-16 Schering Corporation Hydroxy-substituted antifungals
MX9710270A (es) * 1995-06-19 1998-08-30 Schering Corp Fungicidas de tetrahidrofurano.
GB9602080D0 (en) * 1996-02-02 1996-04-03 Pfizer Ltd Pharmaceutical compounds
NZ328607A (en) * 1996-09-09 1999-08-30 Hoffmann La Roche Heterocyclically substituted n-benzyl-azolium derivatives and fungicidal compositions
WO1998021213A2 (en) * 1996-11-12 1998-05-22 Sepracor, Inc. 2r,4s,r,s- and 2s,4r,r,s-hydroxyitraconazole- and hydroxysaperconazole derivatives
EP0938484A1 (en) * 1996-11-12 1999-09-01 Sepracor, Inc. 2r,4s,r,r- and 2s,4r,r,r-hydroxyitraconazole
WO1998021204A1 (en) 1996-11-12 1998-05-22 Sepracor, Inc. 2r,4s,s,s- and 2s,4r,s,s-hydroxyitraconazole
JP2001504464A (ja) * 1996-11-12 2001-04-03 セプラコール,インク. 2r,4s,s,r―および2s,4r,s,r―ヒドロキシイトラコナゾール
KR100509171B1 (ko) 1997-02-11 2005-08-22 얀센 파마슈티카 엔.브이. 아미노산 에스테르를 포함하는 아졸 항진균제
CN100343249C (zh) * 1997-07-11 2007-10-17 詹森药业有限公司 2,4,4-三取代的1,3-二氧环戊烷抗真菌剂
TW593312B (en) * 1997-07-11 2004-06-21 Janssen Pharmaceutica Nv 2,4,4-trisubstituted-1,3-dioxolane antifungals
EP1021439B1 (en) * 1997-10-07 2004-03-31 Schering Corporation Crystalline antifungal polymorph
EP0957101A1 (en) * 1998-05-14 1999-11-17 Janssen Pharmaceutica N.V. Water soluble azoles as broad-spectrum antifungals
US6265584B1 (en) * 1998-05-22 2001-07-24 Bristol-Myers Squibb Company Water soluble prodrugs of azole compounds
AU1915500A (en) 1998-11-20 2000-06-13 Bristol-Myers Squibb Company Water soluble prodrugs of azole compounds
US6362172B2 (en) 2000-01-20 2002-03-26 Bristol-Myers Squibb Company Water soluble prodrugs of azole compounds
US6448401B1 (en) * 2000-11-20 2002-09-10 Bristol-Myers Squibb Company Process for water soluble azole compounds
AR052342A1 (es) * 2004-12-21 2007-03-14 Janssen Pharmaceutica Nv Derivados sustituidos de triazolona,tetrazolona e imidazolona con actividad selectiva antagonista de alfa2c-adenoreceptores
JO2691B1 (en) 2005-05-03 2013-03-03 ايساي آر آند دي مانجمنت كو.، ليمتد Monolysine salts for azole compounds
CN102369198A (zh) * 2008-09-08 2012-03-07 N·吴 三唑抗真菌剂
RU2563811C1 (ru) * 2014-08-08 2015-09-20 Федеральное государственное бюджетное учреждение науки Институт химической физики им. Н.Н. Семенова Российской академии наук (ИХФ РАН) Фармацевтическая композиция для лечения грибковых заболеваний
CN106243087B (zh) * 2016-09-12 2018-10-09 三峡大学 一种三唑吡咯烷酮类杀菌剂,合成方法及其应用
CN111138421A (zh) * 2019-12-26 2020-05-12 上海英诺富成生物科技有限公司 抗真菌水溶性化合物及其制备方法与应用

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4218458A (en) * 1978-06-23 1980-08-19 Janssen Pharmaceutica, N.V. Heterocyclic derivatives of (4-aryloxy-methyl-1,3-dioxolan-2-yl)methyl-1H-imidazoles and 1H-1,2,4-triazoles
CA1292472C (en) * 1985-12-03 1991-11-26 Alfonsus Guilielmus Knaeps Derivatives of ¬¬4-¬4-(4-phenyl-1-piperazinyl)- phenoxymethyl|-1,3-dioxolan-2-yl|methyl|-1h-imidazoles and 1h-1,2,4-triazoles
US4791111A (en) * 1985-12-23 1988-12-13 Janssen Pharmaceutica, N.V. [[4-[4-(4-phenyl-1-piperazinyl)phenoxymethyl]-1,3-dioxolan-2-yl]methyl]-1H-imidazoles and 1H-1,2,4-triazoles having anti-microbial properties
NZ223799A (en) * 1987-03-25 1989-12-21 Janssen Pharmaceutica Nv Azolylmethyl-dioxolanylmethoxyphenyl-piperazinyl-phenyl-triazolones and antimicrobial compositions
US5039676A (en) * 1990-05-11 1991-08-13 Schering Corporation Tri- and tetra-substituted-oxetanes and tetrahydrofurans and intermediates thereof
IL103558A0 (en) * 1991-10-30 1993-03-15 Schering Corp Tri-substituted tetrahydrofuran antifungals
ATE204875T1 (de) * 1993-12-21 2001-09-15 Schering Corp Fungizide tetrahydrofurane

Also Published As

Publication number Publication date
JPH09508360A (ja) 1997-08-26
CZ288544B6 (cs) 2001-07-11
ES2141329T3 (es) 2000-03-16
PH31664A (en) 1999-01-12
DE69513279T2 (de) 2000-07-13
NO963073D0 (no) 1996-07-23
GR3032550T3 (en) 2000-05-31
IL112413A (en) 1999-11-30
ZA95521B (en) 1996-07-23
SG48386A1 (en) 1998-04-17
CN1078210C (zh) 2002-01-23
EP0741737B1 (en) 1999-11-10
AU1535595A (en) 1995-08-08
MY111814A (en) 2001-01-31
CN1138862A (zh) 1996-12-25
LV12634B (lv) 2001-07-20
HU9602008D0 (en) 1996-09-30
PT741737E (pt) 2000-04-28
CY2176B1 (en) 2002-08-23
PL315558A1 (en) 1996-11-12
RU2156764C2 (ru) 2000-09-27
SK282059B6 (sk) 2001-10-08
FI962947A0 (fi) 1996-07-23
CA2179640C (en) 2005-11-15
NO308412B1 (no) 2000-09-11
FI116057B (fi) 2005-09-15
AU688455B2 (en) 1998-03-12
ATE186540T1 (de) 1999-11-15
FI962947A (fi) 1996-07-23
DK0741737T3 (da) 2000-05-22
CA2179640A1 (en) 1995-07-27
HUT75943A (en) 1997-05-28
DE69513279D1 (de) 1999-12-16
PL181947B1 (en) 2001-10-31
HU227281B1 (en) 2011-01-28
JP3764750B2 (ja) 2006-04-12
IL112413A0 (en) 1995-03-30
NZ278882A (en) 1997-06-24
KR100352147B1 (ko) 2002-11-11
CZ195696A3 (en) 1997-02-12
WO1995019983A1 (en) 1995-07-27
EP0741737A1 (en) 1996-11-13
SI0741737T1 (en) 2000-02-29
US5707977A (en) 1998-01-13
NO963073L (no) 1996-07-23
SK89696A3 (en) 1998-02-04
TW376385B (en) 1999-12-11

Similar Documents

Publication Publication Date Title
LV12634A (lv) Watersoluble azole antifungals
CY1120977T1 (el) Θεραπεια των ασθενειων αποθηκευσης γλυκογονου τυπου ιι
BR0113039A (pt) Composto ou um seu sal ou solvato fisiologicamente aceitável, uso do mesmo, composição farmacêutica, formulação farmacêutica em aerossol, método para o tratamento de um indivìduo humano ou animal com uma condição antiinflamatória e/ou alérgica, e, processo para preparar um composto
BR0113838A (pt) Derivados de n-fenil-2-pirimidina-amina
ECSP066311A (es) Derivados de la piperazina y su uso como agentes terapéuticos
BG108318A (en) Carboxamide-substituted phenylurea derivatives and method for the production and use thereof as medicaments
DE50102490D1 (de) Verwendung von substituierten imidazo [1,2-a]pyridin-, -pyrimidin- und -pyrazin-3-yl-amin-derivaten zur herstellung von medikamenten zur nos-inhibierung
CY1109242T1 (el) Θεραπευτικοι παραγοντες χρησιμοι για θεραπεια πονου
NO20093464L (no) Nye medikamentblandinger basert pa anti-cholinergisk effektive forbindelser og beta-mimetika
BR9710737A (pt) Pentafluorobenzenosulfonamidas e análogos.
BR0309343A (pt) Composto, composição farmacêutica, uso de um composto, e, método de tratamento ou profilaxia de doenças ou condições humanas
NO991761L (no) Nye piperidin-kotokarbonsyre-derivater, deres fremstilling og anvendelse
CY1106003T1 (el) Παραγωγα του ν-βενζοϋλοουρεϊδο-κινναμωμικου οξεος, μεθοδος για την παρασκευη τους και η χρηση τους
BR0309342A (pt) Composto, composição farmacêutica, uso de um composto, e, método de tratamento ou profilaxia de doenças ou condições humanas
DE60045508D1 (de) Dalda-analoge und ihre verwendung
HUP0102602A2 (hu) Diacil-hidrazinszármazékok, előállításuk és alkalmazásuk, valamint e vegyületeket tartalmazó gyógyászati készítmények
CA2280727A1 (en) Bicyclic amino acids
NO20024646L (no) Kombinasjonsterapier med vaskul¶r-skadende aktivitet
EE200000527A (et) Faktorit Xa pärssivad heterotsüklilised derivaadid
DE69834500D1 (de) Xanthinderivative zur behandlung von hirnischämie
CY1105591T1 (el) Αναστολεις για συνθαση του 20-ηετε
ATE366107T1 (de) Verwendung von sulfodehydroabietinsäure zur behandlung entzündlicher darmerkrankungen
BR0116302A (pt) Formas cristalinas de sais 2,3-dihidroxibutanodioato de 6-[(4-clorofenil)-hidróxi-(3-metil-3h-imidazol-4-il)-meti l]-4-(3-etinil-fenil)-1-metil-1h-quinolin-2-ona e método de produção
UY28535A1 (es) Derivados de bencimidazol, composiciones que los contienen, preparacion y usos de los mismos.
DE602004022783D1 (de) Heterozyklische harnstoff-derivate für die behandlung von schmerzen.